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1. Introduction  
Disruption of cytoskeletal organization caused by genetic defects in the components of the 
dystrophin-glycoprotein complex (DGC) results in muscular dystrophy and/or 
cardiomyopathy in human patients and animal models. Accumulating evidence obtained 
from studies by using skeletal muscle fibers, cultured myotubes, and cardiac muscle 
preparations from dystrophic animals suggest that defects in DGC components cause 
altered membrane properties in the sarcolemma of myocytes. For example, disruption of the 
DGC can cause increased susceptibility to mechanical stress or increased permeability to 
ions such as Ca2+ and Na+, leading to a chronic increase in the concentrations of intracellular 
Ca2+ ([Ca2+]i) and Na+ ([Na+]i). Abnormal ion homeostasis, especially under conditions of 
mechanical stress, is thought to be a key molecular event in the pathology of muscular 
dysgenesis. In this chapter, we will review the stretch-induced cell damage pathways that 
result in abnormal Ca2+ and Na+ concentrations. In particular, we will focus on stretch-
activated channels, transient receptor potential cation channels, and Na+-dependent ion 
transporters, which have been reported to be of critical pathological significance. We will 
also discuss the therapeutic potential of these ion handling membrane proteins for the 
treatment of muscular dystrophy. 
2. Sarcolemmal weakness and abnormal ion homeostasis in muscular 
dystrophy 
Table 1 shows the genes and their products, which are involved in muscular dystrophy. 
Disruption of some genes (highlighted in pink) lead to heart failure, most often caused by 
dilated cardiomyopathy, as well as muscular dystrophy. In Duchenne muscular dystrophy 
(DMD), in which the protein dystrophin is defective, expression of dystrophin-associated 
proteins is also greatly reduced (Ervasti and Campbell, 1991). In addition, other types of 
muscular dystrophy are caused by mutations in genes encoding the components of the DGC 
(Campbell, 1995; Duclos et al., 1998; Nigro et al., 1997). The DGC is a multi-subunit complex 
(Campbell, 1995; Campbell & Kahl, 1989; Tinsley et al., 1994) that spans the sarcolemma to 
structurally link extracellular matrix proteins such as laminin to the actin cytoskeleton 
(Ervasti & Campbell, 1993), providing mechanical strength to the muscle cell membranes. 
Therefore, disruption of the DGC could significantly destroy membrane integrity or stability 
during contraction/relaxation, and cause cell damage. Importantly, defects in different 
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genes cause similar end-stage symptoms, i.e., muscle dysgenesis. Understanding the 
pathway that leads to cell damage is important for the development of common therapeutic 
strategies, not only for muscular dystrophy, but also for inherited and non-inherited cases of 
dilated cardiomyopathy. Two animal models are commonly used for the study of muscular 
dystrophy: the dystrophin-deficient mouse (mdx), which is representative of human DMD, 
and the delta-sarcoglycan-deficient hamster (BIO14.6), which is a model for human delta-
sarcoglycanopathy.  
 
Table 1. Genes and their products responsible for muscular dystrophy 
In an initial investigation, we found that sarcolemma from BIO14.6 hamster cardiomyopathic 
hearts has a fragile nature and is highly susceptible to mechanical stress, as evidenced by the 
ease of extraction of sarcolemma and T-tubules by relatively weak mechanical 
homogenization in low strength homogenization buffer (Tawada-Iwata et al., 1993). As a 
result, the amount of dystrophin extracted from BIO14.6 hamsters was 5 times more than 
that extracted from control hamsters, despite similar or lower dystrophin expression levels 
in BIO14.6 hamsters (Iwata et al., 1993a). The physical association between dystrophin and 
dystroglycan in BIO14.6 hearts was very weak (Iwata et al., 1993b). Mechanical membrane 
weakness was also observed in the skeletal muscle myotubes from BIO14.6 hamsters. Under 
hypo-osmotic stress (70% osmolarity), extensive cell bleb formation was seen in cultured 
BIO14.6 myotubes; however, this was not observed in control myotubes (Fig.1 A). Similarly, 
bleb formation was also seen in mdx mouse fibers, but not in control fibers (Fig.1 B). Upon 
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cyclic stretching of up to 20% elongation for 1 h, creatine phosphokinase (CK) efflux (a 
marker of cell damage) was elevated with increasing strength of stretch in BIO14.6 
myotubes, but not in controls (Fig.1 C). Such cell damage in mdx myotubes has also been 
reported by other groups (Menke & Jockusch, 1991; Petrof et al., 1993). These data suggest 
that skeletal and cardiac muscle is highly sensitive to mechanical stretch in animal models of 
DGC deficiency.  
 
(A) Hypo-osmotic stress-induced cell damage in cultured dystrophic myotubes. Normal and BIO14.6 
myotubes were preloaded with 5 mM calcein-AM and exposed to hypo-osmotic medium (70% osmolarity) 
for 17 min. Extensive bleb formation was observed in BIO14.6 myotubes (arrow). (B) Hypo-osmotic stress-
induced cell damage in the single skeletal muscle fibers from WT and mdx muscle. Note the extensive bleb 
formation in mdx fibers. (C) Cyclic stretch of up to 20% for 1 h induced CK efflux from BIO14.6 myotubes, 
indicating the high susceptibility of dystrophic myotubes to mechanical stress. (D) Effect of various agents 
on stretch-induced CK efflux. The TRPV2 inhibitor tranilast effectively blocked CK efflux. The Ca2+ channel 
blocker diltiazem, the Ca2+-dependent protease calpain inhibitor E64, and the Ca2+-dependent phosphatase 
calcineurin inhibitor FK506 also blocked CK efflux, suggesting that these Ca2+ handling and Ca2+ effector 
proteins are involved in stretch-induced membrane damage. (E) A stretch-induced Ca2+-permeable 
channel is activated in BIO14.6 myotubes. Positive or negative pressures were applied to the pipette using 
cell-attached patches that were held at -60 mV. BaCl2 (110 mM) was used as the charge carrier. Note the 
higher open probability (NPo) in BIO14.6 myotubes.  
Fig. 1. Mechanical membrane weakness in the DGC-defective myotubes 
It has been reported that myocyte degeneration may be caused by increased membrane 
permeability to Ca2+, which is probably linked with membrane weakness. Many studies have 
reported chronic elevations in [Ca2+]i underneath the sarcolemma, or within other intracellular 
compartments, in the skeletal muscle fibers or myotubes from DMD patients and mdx mice 
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(Brown, 1997; Mallouk et al., 2000; Robert et al., 2001). Elevated [Ca2+]i has been causally linked 
to a greater rate of protein degradation, catalyzed by the Ca2+-dependent protease calpain 
(Alderton & Steinhardt, 2000a; MacLennan et al., 1991; Spencer et al., 1995; Turner et al., 1988). 
Concurrently, myocyte contractile activity would cause physical damage to the sarcolemma, 
leading to leakage of cytosolic enzymes such as CK. The [Ca2+]i in the muscle tissue is 
regulated by numerous ion channels, Ca2+ pumps, and transporters in the sarcolemma and 
sarcoplasmic reticulum (SR). Of these, the sarcolemmal Ca2+-permeable channels (Ca2+-specific 
leak channels) or the mechanosensitive non-selective cation channels, which contribute to 
abnormal Ca2+ handling in dystrophic myocytes, have been the focus of attention.  
In 1990, the Steinhardt group (Fong et al., 1990) reported the existence of Ca2+ leak channels 
with a higher open probability in myotubes from mdx mice or DMD patients. These 
channels were activated by the L-type Ca2+ channel blocker nifedipine, but inhibited by the 
other dihydropyridine compounds AN406 and AN1043 (Alderton et al., 2000a). Treatment 
with the calpain inhibitor leupeptin decreased opening probabilities of the leak channels 
and prevented elevation in resting [Ca2+]i in mdx myotubes (Turner et al., 1993). The leak 
channels were activated by store depletion in control myotubes (Hopf et al., 1996). From 
these data, Steinhardt et al. proposed a mechanism of myocyte degeneration caused by leak 
channel activation; contraction-induced sarcolemmal tears in dystrophin-deficient myotubes 
lead to localized Ca2+ entry, which initiates the repair of the defect. Activation of proteolysis 
is thought to be essential for the activation of leak channels, which accelerate Ca2+ entry and 
further increase Ca2+–dependent proteolysis, the final common pathway of cell damage 
(Alderton & Steinhardt, 2000b). However, molecular identification and characterization of 
Ca2+ leak channels has not been carried out. 
Mechanosensitive stretch-activated channels (SACs) have been described to contribute to 
increased Ca2+ permeability in dystrophic myotubes. The open probability of these channels 
increases when negative pressure is applied to a patch pipette. This is observed in both 
control and mdx muscle, but to a greater extent in mdx myotubes and fibers (Franco-Obregon 
& Lansman, 1994). SACs are non-selective cation channels permeable to Na+, K+, Ca2+, and 
Ba2+, and have a conductance of 13 pS when a patch pipette is filled with 110 mM Ca2+ 
(Franco & Lansman, 1990). In addition, a stretch-inactivated channel has been reported to 
exist only in mdx muscle cells (Franco et al., 1990), which was later reported to have identical 
conductance properties to SACs (Franco-Obregon & Lansman, 2002). These channels are 
blocked by Gd3+, streptomycin (Hamill & McBride, 1996), and the spider venom toxin 
GsMtx4 (Suchyna et al., 2000). Abnormalities in SACs have been detected in the recordings 
from the muscle biopsy samples of DMD patients (Vandebrouck et al., 2001; Vandebrouck et 
al., 2002a). These results suggest that SACs are important for pathological Ca2+ entry into the 
dystrophin-deficient muscle, at early stages of the pathogenesis. 
Research has shown that store-operated Ca2+ channels (SOCs) may also be involved in the 
pathogenesis of muscular dystrophy. SOCs have voltage-independent properties and a 
unitary conductance between 7 and 8 pS (with 110 mM Ca2+ in a patch pipette). Their open 
probability increases when luminal Ca2+ in the SR is depleted by the Ca2+ pump inhibitor 
thapsigargin. SOC activity was reported to be about twice as high in mdx compared to wild-
type mice, and contributes to increased [Ca2+]i in DMD (Vandebrouck et al., 2002b). 
Recently, Ca2+-independent phospholipase A2 was found to be localized in the sarcolemma 
of mdx muscle, and its enzymatic product, lysophosphatidylcholine, was found to trigger 
Ca2+ entry through SOCs (Boittin et al., 2006). SACs and SOCs share several biophysical and 
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pharmacological properties in adult muscle fibers; they have the same unitary conductance, 
and a similar sensitivity to Gd3+, SKF-96365, 2-aminoethoxydiphenyl borate (2-APB), 
GsMTx4 toxin, and IGF-1 stimulation (Ducret et al., 2006). These observations suggest that 
SACs and SOCs may share common constituents, although molecular identification of these 
components is still required.  
3. Therapeutic targets for muscular dystrophy 
3.1 TRPV channels 
Since a large body of evidence indicates the pathological significance of increased [Ca2+]i in 
muscular dystrophy, much effort has been made to identify the genes responsible for 
abnormal Ca2+ handling in this disease. Our group has shown that stretch-sensitive cation-
selective channels, similar to those recorded in mdx skeletal muscle, are active in cultured 
myotubes prepared from BIO14.6 hamsters (Nakamura et al., 2001). Positive or negative 
pressure increases the open probability of this channel in BIO14.6 myotubes (Fig.1 E). To 
identify the Ca2+ entry pathway responsible for myocyte degeneration, we searched for 
mammalian homologs of the Drosophila stretch sensor NompA, which were expressed in the 
striated muscle. We were successful in identifying a candidate that belongs to the transient 
receptor potential (TRP) channel family, which is similar to NompA. Many members of this 
family are Ca2+-permeable cation channels sensitive to physical stimuli such as osmotic stress 
or heat (Montell et al., 2002). The candidate channel was previously reported as growth factor 
responsive channel (GRC) (Kanzaki et al., 1999), and later renamed TRP vanilloid type 2 
(TRPV2) channel. We showed that TRPV2 is activated by mechanical stimuli and plays a 
critical role in the pathogenesis of muscular dystrophy and cardiomyopathy (Iwata et al., 2003; 
Muraki et al., 2003). TRPV2 is normally localized in the intracellular membrane compartment, 
but translocates to the plasma membrane in response to stretch or growth factor stimulation. 
Importantly, TRPV2 was observed to accumulate in the sarcolemma of the skeletal muscle 
from human patients with muscular dystrophy, BIO14.6 hamsters, and mdx mice (Fig.2) (Iwata 
et al., 2003), thus contributing to a sustained increase in [Ca2+]i in diseased myocytes.  
 
TRPV2 was immunolocalized in the frozen sections of the skeletal muscle from dystrophic patients and 
a non-dystrophic control, or from wild-type and dystrophic animals (Iwata et al., 2003). Note extensive 
sarcolemmal localization of TRPV2 in dystrophic patients and animal models. Bars, 50 m. 
Fig. 2. Immunohistochemical localization of TRPV2 
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In order to determine whether TRPV2 contributes to Ca2+-induced muscle damage, we used 
a dominant-negative mutant strategy. We produced loss-of-function TRPV2 mutants in the 
pore region of the protein, which have a dominant-negative effect on the channel function 
by forming a non-functional oligomer, thereby abrogating the activity of endogenous 
TRPV2 (Fig.3 A). This dominant-negative TRPV2 mutant was incorporated into mdx mice by 
using a transgenic strategy or into BIO14.6 hamsters by adenoviral transfer. We found that 
these approaches significantly reduced resting [Ca2+]i as well as the increase in [Ca2+]i induced 
by high Ca2+ and the TRPV2 agonist 2-APB observed in dystrophic muscles (Fig.3 B).  
 
(A) Transgenic (Tg) mice overexpressing the TRPV2 mutant with a mutation in the putative pore region 
(Glu604) were produced, and crossed with mdx mice to introduce dnTRPV2 and inhibit endogenous 
TRPV2 activity. ANK, ankyrin repeat domain. HA, epitope tag. (B) Agonist (2-APB)-induced [Ca2+]i 
increase in the isolated flexor digitorum brevis fibers of mdx mice, which is inhibited by ruthenium red 
(RR) (left). Note that no large [Ca2+]i increase was detected in the fibers from wild-type mice. Such 
[Ca2+]i increases in the mdx fibers were markedly reduced by expression of dnTRPV2 (mdx/Tg) (right) 
(Iwata et al., 2009). 
Fig. 3. Production of a dominant-negative (dn) TRPV2 mutant 
Transgenic or adenoviral expression of dnTRPV2 resulted in a 40%–70% reduction of 
impaired muscle function, as determined by an increased number of central nuclei and 
improvements in fiber size variability, fibrosis, apoptosis, elevated serum creatine kinase 
levels, and reduced muscle performance in dystrophic animals (Fig.4 A) (Iwata et al., 2009). 
Furthermore, mdx muscles were largely protected from eccentric work-induced force drop 
by the same transgenic strategy (Zanou et al., 2009). These results suggest that the entry of 
Ca2+ through TRPV2 channels precedes and is involved in membrane damage. Interestingly, 
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expression of dnTRPV2 also promoted the removal of endogenous TRPV2 from the 
sarcolemma (Fig.4 B), suggesting that Ca2+ entering the cell via TRPV2 is required for the 
sarcolemmal retention of TRPV2 expression in dystrophic muscles. The pathological 
importance of TRPV2 was also verified using a pharmacological approach. A non-selective 
cation channel blocker tranilast was shown to be an effective inhibitor of TRPV2 (Iwata et 
al., 2005). Oral administration of tranilast reduced various symptoms of muscular 
dystrophy, such as elevated serum CK levels, progressive muscle degeneration, and 
increased infiltration of immune cells (Fig.5 A) (Iwata et al., 2005). Therefore, specific 
inhibitors of TRPV2 could be potentially useful and effective treatments for various muscle 
degenerative diseases, including hereditary diseases.  
Although the relationship between muscular dystrophy and other types of TRPV channel 
has not yet been investigated, TRPV4 was recently identified as a responsive gene in 
inherited neurodegenerative disease, which indirectly causes muscle atrophy (Deng et al., 
2010; Landoure et al., 2010).  
 
(A) Masson’s trichrome staining (left) or TUNEL labeling (right) of the gastrocnemius muscle sections 
from mdx (a) or mdx/Tg (b) mice. Note the beneficial effect of dnTRPV2 (mdx/Tg). Scale bar, 100 m. (B) 
Immunohistochemical analysis of TRPV2 (a-d) and dystrophin (i-l) in frozen cross sections of skeletal 
muscle. Dominant negative TRPV2 was immunolocalized with rat anti-HA (e-h). Note the removal of 
TRPV2 from the sarcolemma promoted by dnTRPV2 (mdx/Tg). Scale bar, 50 m.  
Fig. 4. Dominant-negative TRPV2 prevents muscle degeneration in mdx mice  
3.2 TRPC channels  
TRPC channels represent another important candidate for a therapeutic target in the 
treatment of muscular dystrophy. TRPC1, 4, and 6 are expressed in the sarcolemma of the 
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skeletal muscle (Vandebrouck et al., 2002b). Knockdown of TRPC1 and TRPC4, but not 
TRPC6, was reported to reduce abnormal Ca2+ influx in dystrophic fibers (Vandebrouck et 
al., 2002b). TRPC1 has been shown to form the stretch-activated channel (Maroto et al., 
2005), although contrary data also exists (Gottlieb et al., 2008). TRPC1, together with its 
binding partner caveolin-3, accumulates at higher levels in the sarcolemma of the 
dystrophin-deficient muscle and contributes to abnormal Ca2+ influx, which is activated by 
reactive oxygen species and Src kinase (Allen & Whitehead, 2011; Gervasio et al., 2008). 
Furthermore, mice lacking the scaffolding protein Homer-1, which interacts with TRPC1, 
exhibit myopathy associated with increased spontaneous cation influx (Stiber et al., 2008b). 
A recent study (Millay et al., 2009) also showed that overexpression of TRPC3 resulted in a 
phenotype of muscular dystrophy nearly identical to that observed in dystrophic animal 
models with abnormal DGC. Transgene-mediated inhibition of TRPC channels dramatically 
reduced the dystrophic phenotype in this animal model. These results suggest that Ca2+ 
entry through TRPC channels is sufficient to induce muscular dystrophy in vivo, and that 
TRPC channels are also promising therapeutic targets for muscular dysgenesis.  
3.3 STIM1 and Orai1 
Recently, the molecules involved in store-operated Ca2+ entry (SOCE) were identified. 
Stromal interaction molecules (STIM) were identified as the endoplasmic reticulum (ER) 
Ca2+ sensor, and found to interact with sarcolemmal Orai1 channels after Ca2+ store 
depletion to trigger SOCE. STIM1 and Orai1 are highly expressed in skeletal muscle: STIM1 
is pre-localized at junctions of the SR with the T-tubule system, which contains pre-localized 
Orai1 (Stiber et al., 2008a). STIM1/Orai1 couples with TRPC channels (Dirksen, 2009) and 
the resulting STIM1/Orai1/TRPC1 ternary complexes have been shown to assemble during 
store depletion, thereby contributing to SOCE (Yuan et al., 2007; Zeng et al., 2008). Recently, 
the amount of STIM1/Orai1 proteins was reported to be upregulated in mdx muscle fibers, 
and the thresholds for the activation and deactivation of SOCE shifted to higher SR Ca2+ 
concentrations. This contributes to increased Ca2+ influx during long stimulation periods in 
mdx muscles (Edwards et al., 2010). In contrast, knockdown or inhibition of STIM1/Orai1 
function was reported to cause myopathy resulting from impaired muscle development, 
which is different to muscular dystrophy caused by DGC defects. For example, mice lacking 
either STIM1 or Orai1 display skeletal muscle myopathy (Stiber et al., 2008a), and severe 
combined immunodeficiency patients characterized by loss-of-function mutations in 
STIM1/Orai1 signaling display similar skeletal muscle myopathy (Feske et al., 2006). 
Knockdown of STIM1 or expression of the Orai1 dominant negative E106Q caused a marked 
decrease in SOCE in skeletal muscle myotubes (Lyfenko & Dirksen, 2008). These findings 
suggest that STIM1/Orai1 proteins are involved in the fine-tuning of Ca2+ regulation, and 
physiological levels are required for normal skeletal muscle function. 
3.4 Na
+
-dependent ion transporters  
In addition to [Ca2+]i, [Na+]i is also reported to be elevated in skeletal muscle of mdx mice 
(Dunn et al., 1993). The increase in [Na+]i is accompanied by a compensatory increase in 
membrane-bound Na+/K+ ATPase contents (Dunn et al., 1995). A possible cause of 
increased [Na+]i in the mdx skeletal muscle may be enhanced activity of stretch-activated 
channels, since it was inhibited by Gd3+ and streptomycin, which are known to be broad 
inhibitors of this channel type (Yeung et al., 2003a; Yeung et al., 2003b). It has also been 
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shown that increases in [Na+]i under the sarcolemma in mdx mice may be due to alterations 
in localization and gating properties of Nav1.4; the skeletal muscle isoform of the voltage-
gated sodium channel may be correlated with increased cell death because [Na+]i overload is 
reversed by tetrodotoxin, a specific Nav1.4 blocker (Hirn et al., 2008). 
Recently, we have shown that the sarcolemmal Na+/H+ exchanger (NHE), which is known 
to be stimulated in response to various stimuli, including growth factors and osmotic stress, 
is significantly activated in dystrophic myocytes (from BIO14.6 hamsters). This is evidenced 
by an alkaline shift in the intracellular pH (pHi) dependent on NHE activity, enhanced 22Na+ 
influx, and elevated [Na+]i (Iwata et al., 2007). In dystrophic myotubes, NHE was found to 
be a major Na+ influx pathway, since the specific NHE inhibitor cariporide markedly (65%) 
inhibited it. Interestingly, NHE inhibition also significantly reduced the increase in 
intracellular Ca2+ and stretch-induced CK release in dystrophic myotubes, and ameliorated 
myopathic damage in vivo (Fig.5 B) (Iwata et al., 2007), indicating that the inhibition of NHE 
protects muscle cells against injury. Elevation in [Na+]i may contribute to abnormal Ca2+ 
homeostasis by influencing the activity of the Na+/Ca2+ exchanger.  
  
(A) Beneficial effect of the Ca2+-handling drugs diltiazem and tranilast. Chemicals were administered 
orally to 30-day-old BIO14.6 hamsters for 60 or 120 days. The TRPV2 inhibitor tranilast effectively reduces 
CK release (left) and prevents muscle degeneration (H&E staining, right) (Iwata et al., 2005). (B) Beneficial 
effect of the P2 receptor antagonist suramin (sur) and the NHE inhibitor cariporide (car). In particular, note 
an excellent amelioration of muscle degeneration by combined administration of the two chemicals 
(Masson’s trichrome staining of the quadriceps muscle sections, right) (Iwata et al., 2007). Scale bar, 100 m.  
Fig. 5. Effects of pharmacological agents on muscle degeneration in BIO14.6 hamsters  
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Furthermore, ATP was released more easily from the dystrophic myotubes in response to 
mechanical stretch. Thus, it is likely that P2 receptor stimulation with ATP activates the 
NHE, thereby leading to [Ca2+]i overload (Iwata et al., 2007). These molecules also represent 
good targets for muscular dystrophy therapy. In fact, combined treatment with the P2 
receptor antagonist suramin and the NHE1-specific inhibitor cariporide resulted in efficient 
amelioration of muscular dystrophy in BIO14.6 hamsters (Fig.5 B). 
3.5 SR proteins  
Recently, the occurrence of increased Ca2+ sparks, an indication of abnormalities in the SR 
Ca2+ release channel ryanodine receptor (RyR1), was reported in dystrophic fibers (Bellinger 
et al., 2009; Wang et al., 2005). RyR1 from mdx mice were shown to be excessively cystein-
nitrosylated, which was coupled with depletion of calstabin-1 (calcium channel-stabilizing 
binding protein-1, also known as FKBP12) from RyR1. As a consequence, this led to 
increased spontaneous RyR1 openings (Ca2+ sparks), and reduced specific muscle force. 
Prevention of calstabin-1 depletion from RyR1 inhibited SR Ca2+ leak, reduced muscle 
damage, improved muscle function, and increased exercise performance in mdx mice 
(Bellinger et al., 2009).  
One strategy to reduce the effects associated with chronic Ca2+ leak from activated channels 
and membrane rupture is to increase the rate of Ca2+ reuptake into the SR, by overexpression 
of the SR Ca2+ pump SERCA1. Indeed, transgenic overexpression of SERCA1 dramatically 
rescued the dystrophic phenotype of delta-sarcoglycan-null mice (Goonasekera et al., 2011). 
Furthermore, Ca2+ removal by adenovirus-mediated overexpression of SERCA1a reduced 
susceptibility to contraction-induced damage in mdx mice (Morine et al., 2010). These results 
suggest that Ca2+ is a common risk factor in the transmission of most genetic defects to 
downstream necrosis pathways in muscular dystrophy. Thus, control of [Ca2+]i would provide 
a universal therapeutic strategy that reduces the dystrophic phenotype.  
3.6 Other candidates  
Dystrophic muscles are always exposed to oxidative and immune stress, as well as 
mechanical stress. Although not discussed in detail in this chapter, there are many 
important stress-dependent factors leading to muscle injury in muscular dystrophy (Lawler, 
2011; Tidball & Wehling-Henricks, 2007). For example, NADPH oxidase in the muscles was 
recently reported to be an important source of oxidative stress, which stimulates stretch-
activated Ca2+ entry in dystrophic muscles (Whitehead et al., 2010). Futhermore, nitric oxide 
(NO) synthase in macrophages may be another risk factor that promotes membrane injury 
in dystrophic muscles (Villalta et al., 2009). Therapeutic interventions that regulate stress 
pathways may be useful in protecting against dystrophic phenotypes.  
4. Conclusion 
As described above, disruption of the DGC results in increased mechanical stress and 
abnormal ion homeostasis. Sustained increases in [Ca2+]i are the key pathological event 
leading to muscle degeneration (Fig.6). Many key players contribute to abnormal Ca2+ 
handling. Among these molecules, we consider TRPV2 to have high therapeutic potential 
for the treatment of muscular dystrophy, because most TRPV2 localizes to the intracellular 
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Fig. 6. Schematic drawing showing a possible pathway leading to abnormal Ca2+ handling 
and subsequent muscle degeneration in DGC-defective dystrophic muscles, according to 
our recent studies (Iwata et al., 2003; 2009; 2007; 2005) Increased mechanical stress caused by 
DGC defects induces sarcolemmal translocation and TRPV2 activation, leading to sustained 
[Ca2+]i increase. On the other hand, mechanical stress also induces release of bioactive 
substances such as ATP and growth factors, which, in turn, activates NHE, increases [Na+]i, 
and results in further increase in [Ca2+]i via inhibition of the NCX forward mode. Ca2+ 
handling proteins in the SR may also contribute to cytosolic Ca2+ overload. Therapeutic 
intervention at the level of Ca2+-handling proteins would be useful for reducing the 
dystrophic phenotype.  
membranes in the healthy skeletal muscles, while it translocates to the surface membrane 
upon muscle degeneration. Hence, specific inhibitors against TRPV2 are expected to act only 
on degenerative muscles. Given the lack of a definitive strategy to cure muscular dystrophy, 
identifying new therapeutic targets appears to be extremely important. We hope that this 
chapter might help to provide an opportunity to promote such studies.  
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